ONTOLOGY REPORT - ANNOTATIONS
| Term: | Aroclor 1254 |
|
| Accession: | CHEBI:63933
|
browse the term
|
| Definition: | A mixture of polychlorobiphenyls of unspecified composition, containing 54% chlorine (X = Cl or H). |
| Synonyms: | related_synonym: | *c1c(*)c(*)c(c(*)c1*)-c1c(*)c(*)c(*)c(*)c1*; C12; Chlorierte biphenyle, chlorgehalt 54%; Chlorodiphenyl (54% Chlorine); Diphenyle chlore, 54% de chlore; Polychlorobiphenyls (54% chlorine) |
| | xref_casrn: | 11097-69-1 |
| | xref: | ChemIDplus:11097-69-1 "CAS Registry Number"; CiteXplore:19486918 "PubMed citation"; CiteXplore:19772856 "PubMed citation"; CiteXplore:19945719 "PubMed citation"; CiteXplore:21476350 "PubMed citation"; CiteXplore:21613298 "PubMed citation"; CiteXplore:21664404 "PubMed citation"; CiteXplore:21748531 "PubMed citation"; CiteXplore:21856390 "PubMed citation"; CiteXplore:21937113 "PubMed citation"; CiteXplore:22013134 "PubMed citation"; CiteXplore:22044768 "PubMed citation"; CiteXplore:22082211 "PubMed citation"; CiteXplore:22094459 "PubMed citation"; CiteXplore:22298839 "PubMed citation" |
| | xref_mesh: | MESH:D020111 |
| | xref: | Reaxys:8188376 "Reaxys Registry Number" |
|
|
Aroclor 1254
|
| G |
Aadat |
aminoadipate aminotransferase |
|
decreases expression |
EXP |
16 |
32,845,006 |
32,885,600 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Acadsb |
acyl-CoA dehydrogenase, short/branched chain |
|
increases expression |
EXP |
1 |
190,987,657 |
191,026,275 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases activity |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acp2 |
acid phosphatase 2, lysosomal |
|
increases expression |
EXP |
3 |
75,559,522 |
75,568,415 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
increases expression |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
decreases expression |
EXP |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Aff4 |
AF4/FMR2 family, member 4 |
|
decreases expression |
ISO |
10 |
38,798,873 |
38,883,154 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
decreases expression |
EXP |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
increases expression |
EXP |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Anapc11 |
anaphase promoting complex subunit 11 |
|
decreases expression |
ISO |
10 |
109,988,502 |
109,999,500 |
RGD:6480464 |
CTD |
| G |
Anapc5 |
anaphase-promoting complex subunit 5 |
|
increases expression |
ISO |
12 |
34,850,485 |
34,884,726 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions |
EXP |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
decreases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
affects expression |
ISO |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
increases expression |
EXP |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
decreases secretion |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
decreases expression |
EXP |
7 |
67,120,782 |
67,127,697 |
RGD:6480464 |
CTD |
| G |
Banp |
Btg3 associated nuclear protein |
|
increases expression |
ISO |
19 |
52,193,660 |
52,268,521 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
increases expression |
ISO |
4 |
144,139,486 |
144,145,186 |
RGD:6480464 |
CTD |
| G |
Bmf |
Bcl2 modifying factor |
|
increases expression |
ISO |
3 |
104,966,652 |
104,984,752 |
RGD:6480464 |
CTD |
| G |
Btg1 |
B-cell translocation gene 1, anti-proliferative |
|
decreases expression |
ISO |
7 |
34,029,300 |
34,031,557 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Card10 |
caspase recruitment domain family, member 10 |
|
decreases expression |
ISO |
7 |
116,737,928 |
116,766,959 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccbl1 |
cysteine conjugate-beta lyase, cytoplasmic |
|
increases expression |
EXP |
3 |
9,195,737 |
9,209,545 |
RGD:6480464 |
CTD |
| G |
Ccnt2 |
cyclin T2 |
|
increases expression |
ISO |
13 |
40,498,884 |
40,540,130 |
RGD:6480464 |
CTD |
| G |
Cct6b |
chaperonin containing Tcp1, subunit 6B (zeta 2) |
|
increases expression |
EXP |
10 |
72,107,076 |
72,144,993 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
decreases expression |
ISO |
8 |
114,237,704 |
114,255,971 |
RGD:6480464 |
CTD |
| G |
Cdc26 |
cell division cycle 26 |
|
decreases expression |
ISO |
5 |
79,390,026 |
79,403,683 |
RGD:6480464 |
CTD |
| G |
Cdc34 |
cell division cycle 34 |
|
increases expression |
EXP |
7 |
11,534,543 |
11,539,941 |
RGD:6480464 |
CTD |
| G |
Cdk11b |
cyclin-dependent kinase 11B |
|
increases expression |
ISO |
5 |
172,459,111 |
172,486,012 |
RGD:6480464 |
CTD |
| G |
Cdk20 |
cyclin-dependent kinase 20 |
|
increases expression |
ISO |
17 |
6,221,255 |
6,227,959 |
RGD:6480464 |
CTD |
| G |
Cdk9 |
cyclin-dependent kinase 9 |
|
increases expression |
ISO |
3 |
11,672,861 |
11,677,709 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
decreases expression |
EXP |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Ceacam10 |
carcinoembryonic antigen-related cell adhesion molecule 10 |
|
increases expression |
EXP |
1 |
80,070,252 |
80,076,528 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression |
EXP |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
decreases expression |
ISO |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
decreases phosphorylation |
EXP |
1 |
208,133,876 |
208,137,408 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
multiple interactions |
EXP |
1 |
208,133,876 |
208,137,408 |
RGD:6480464 |
CTD |
| G |
Cfp |
complement factor properdin |
|
increases expression |
EXP |
X |
12,584,709 |
12,590,271 |
RGD:6480464 |
CTD |
| G |
Cgrrf1 |
cell growth regulator with ring finger domain 1 |
|
decreases expression |
ISO |
15 |
22,683,387 |
22,703,833 |
RGD:6480464 |
CTD |
| G |
Chfr |
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
12 |
46,651,265 |
46,684,689 |
RGD:6480464 |
CTD |
| G |
Cideb |
cell death-inducing DFFA-like effector b |
|
decreases expression |
ISO |
15 |
33,916,472 |
33,920,872 |
RGD:6480464 |
CTD |
| G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
|
increases expression |
ISO |
X |
90,301,067 |
90,305,762 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
decreases activity |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
multiple interactions |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
|
decreases expression |
ISO |
7 |
55,823,982 |
55,880,812 |
RGD:6480464 |
CTD |
| G |
Coa5 |
cytochrome C oxidase assembly factor 5 |
|
decreases expression |
EXP |
9 |
36,365,008 |
36,375,515 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
increases expression |
EXP |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpa2 |
carboxypeptidase A2 (pancreatic) |
|
decreases expression |
EXP |
4 |
57,452,111 |
57,475,357 |
RGD:6480464 |
CTD |
| G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
|
increases expression |
ISO |
7 |
32,504,279 |
32,517,581 |
RGD:6480464 |
CTD |
| G |
Creb3 |
cAMP responsive element binding protein 3 |
|
increases expression |
ISO |
5 |
60,040,874 |
60,045,512 |
RGD:6480464 |
CTD |
| G |
Creb3l1 |
cAMP responsive element binding protein 3-like 1 |
|
increases expression |
ISO |
3 |
76,361,149 |
76,401,633 |
RGD:6480464 |
CTD |
| G |
Crip2 |
cysteine-rich protein 2 |
|
decreases expression |
EXP |
6 |
138,147,462 |
138,152,407 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
increases expression |
EXP |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases activity |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects response to substance |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases activity |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
1 |
82,006,828 |
82,020,282 |
RGD:6480464 |
CTD |
| G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
1 |
82,006,828 |
82,020,282 |
RGD:6480464 |
CTD |
| G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
1 |
82,006,828 |
82,020,282 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases expression |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases activity |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b15 |
cytochrome P450, family 2, subfamily b, polypeptide 15 |
|
increases expression |
EXP |
1 |
81,839,930 |
81,852,366 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c23 |
cytochrome P450, family 2, subfamily c, polypeptide 23 |
|
decreases expression |
EXP |
1 |
249,204,049 |
249,228,689 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
increases expression |
EXP |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
increases expression |
ISO |
1 |
244,400,004 |
244,493,624 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
increases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
increases expression |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a2 |
cytochrome P450, family 4, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
5 |
135,765,673 |
135,773,006 |
RGD:6480464 |
CTD |
| G |
Dapk3 |
death-associated protein kinase 3 |
|
increases expression |
ISO |
7 |
10,007,997 |
10,016,365 |
RGD:6480464 |
CTD |
| G |
Dld |
dihydrolipoamide dehydrogenase |
|
increases expression |
EXP |
6 |
49,185,188 |
49,205,894 |
RGD:6480464 |
CTD |
| G |
Dpysl4 |
dihydropyrimidinase-like 4 |
|
increases expression |
EXP |
1 |
198,866,034 |
198,881,902 |
RGD:6480464 |
CTD |
| G |
Eaf2 |
ELL associated factor 2 |
|
decreases expression |
ISO |
11 |
65,763,410 |
65,809,967 |
RGD:6480464 |
CTD |
| G |
Emp3 |
epithelial membrane protein 3 |
|
decreases expression |
ISO |
1 |
96,389,783 |
96,392,960 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
increases expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
|
decreases expression |
EXP |
1 |
21,087,402 |
21,159,925 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
decreases expression |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Exoc3 |
exocyst complex component 3 |
|
increases expression |
EXP |
1 |
29,897,536 |
29,928,281 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
increases expression |
ISO |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Foxn3 |
forkhead box N3 |
|
increases expression |
ISO |
6 |
123,385,156 |
123,762,322 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
decreases expression |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
decreases expression |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Gaa |
glucosidase, alpha, acid |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
multiple interactions |
EXP |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gad2 |
glutamate decarboxylase 2 |
|
multiple interactions |
EXP |
17 |
96,259,430 |
96,321,857 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression |
EXP |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression |
EXP |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
increases expression |
EXP |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Gmps |
guanine monphosphate synthetase |
|
increases expression |
EXP |
2 |
153,804,512 |
153,840,009 |
RGD:6480464 |
CTD |
| G |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
|
decreases expression |
EXP |
5 |
60,506,171 |
60,536,403 |
RGD:6480464 |
CTD |
| G |
Gnmt |
glycine N-methyltransferase |
|
decreases expression |
EXP |
9 |
10,127,092 |
10,130,444 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression |
EXP |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
ISO |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
decreases expression |
EXP |
16 |
7,073,038 |
7,108,830 |
RGD:6480464 |
CTD |
| G |
Hbp1 |
HMG-box transcription factor 1 |
|
decreases expression |
ISO |
6 |
50,201,281 |
50,227,095 |
RGD:6480464 |
CTD |
| G |
Hcfc1 |
host cell factor C1 |
|
decreases expression |
ISO |
X |
159,875,671 |
159,900,536 |
RGD:6480464 |
CTD |
| G |
Hey1 |
hairy/enhancer-of-split related with YRPW motif 1 |
|
increases expression |
ISO |
2 |
95,174,030 |
95,176,430 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases expression |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf1a |
HNF1 homeobox A |
|
increases expression |
EXP |
12 |
42,919,574 |
42,945,670 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
increases expression |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hoxb6 |
homeo box B6 |
|
increases expression |
ISO |
10 |
85,030,558 |
85,033,604 |
RGD:6480464 |
CTD |
| G |
Hoxb7 |
homeo box B7 |
|
increases expression |
ISO |
10 |
85,017,440 |
85,020,858 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
increases expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
increases expression |
EXP |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
decreases activity |
EXP |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
decreases expression |
EXP |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
decreases activity |
EXP |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
|
multiple interactions |
EXP |
17 |
6,554,164 |
6,585,525 |
RGD:6480464 |
CTD |
| G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
|
decreases expression |
EXP |
17 |
6,554,164 |
6,585,525 |
RGD:6480464 |
CTD |
| G |
Hsd3b |
3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase type II |
|
decreases activity |
EXP |
2 |
193,387,391 |
193,388,559 |
RGD:6480464 |
CTD |
| G |
Hsd3b |
3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase type II |
|
decreases activity |
EXP |
2 |
193,387,391 |
193,388,559 |
RGD:6480464 |
CTD |
| G |
Hsd3b |
3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase type II |
|
decreases expression |
EXP |
2 |
193,387,391 |
193,388,559 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
multiple interactions |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
decreases expression |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
decreases activity |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
multiple interactions |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
increases expression |
EXP |
10 |
38,705,629 |
38,749,058 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
increases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
ISO |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
increases expression |
EXP |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Htra1 |
HtrA serine peptidase 1 |
|
affects expression |
ISO |
1 |
190,257,899 |
190,308,325 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
decreases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
decreases expression |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
decreases expression |
EXP |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
decreases expression |
ISO |
1 |
201,456,689 |
201,459,756 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Klf12 |
Kruppel-like factor 12 |
|
increases expression |
ISO |
15 |
83,686,143 |
84,046,291 |
RGD:6480464 |
CTD |
| G |
Klf13 |
Kruppel-like factor 13 |
|
increases expression |
ISO |
1 |
118,368,164 |
118,398,938 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
affects localization |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
decreases expression |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
decreases expression |
EXP |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Limk1 |
LIM domain kinase 1 |
|
decreases expression |
EXP |
12 |
23,091,809 |
23,125,717 |
RGD:6480464 |
CTD |
| G |
Limk1 |
LIM domain kinase 1 |
|
multiple interactions |
EXP |
12 |
23,091,809 |
23,125,717 |
RGD:6480464 |
CTD |
| G |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
|
increases expression |
ISO |
20 |
37,349,188 |
37,397,427 |
RGD:6480464 |
CTD |
| G |
Lss |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
increases expression |
EXP |
20 |
12,507,575 |
12,534,612 |
RGD:6480464 |
CTD |
| G |
Mad2l1 |
MAD2 mitotic arrest deficient-like 1 (yeast) |
|
decreases expression |
ISO |
4 |
96,380,039 |
96,386,042 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Masp1 |
mannan-binding lectin serine peptidase 1 |
|
increases expression |
EXP |
11 |
79,532,504 |
79,602,755 |
RGD:6480464 |
CTD |
| G |
Mbd1 |
methyl-CpG binding domain protein 1 |
|
decreases expression |
ISO |
18 |
71,068,257 |
71,082,734 |
RGD:6480464 |
CTD |
| G |
Mcrs1 |
microspherule protein 1 |
|
increases expression |
ISO |
7 |
138,002,551 |
138,011,365 |
RGD:6480464 |
CTD |
| G |
Mdh2 |
malate dehydrogenase 2, NAD (mitochondrial) |
|
increases expression |
EXP |
12 |
22,021,302 |
22,034,257 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
increases expression |
EXP |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
increases expression |
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:6480464 |
CTD |
| G |
Mettl7b |
methyltransferase like 7B |
|
increases expression |
EXP |
7 |
2,269,393 |
2,272,039 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
decreases expression |
EXP |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mllt6 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
|
decreases expression |
ISO |
10 |
86,413,002 |
86,431,124 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mtcp1 |
mature T-cell proliferation 1 |
|
decreases expression |
ISO |
18 |
108,513 |
109,372 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
increases expression |
ISO |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
|
decreases expression |
ISO |
17 |
29,304,750 |
29,354,613 |
RGD:6480464 |
CTD |
| G |
Nek6 |
NIMA-related kinase 6 |
|
increases expression |
ISO |
3 |
18,348,698 |
18,381,895 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
increases expression |
ISO |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nfatc3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
increases expression |
ISO |
19 |
35,907,800 |
35,982,095 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
decreases expression |
EXP |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nin |
ninein (GSK3B interacting protein) |
|
decreases expression |
ISO |
6 |
92,135,196 |
92,229,044 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
increases expression |
ISO |
19 |
35,094,345 |
35,096,012 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Npas2 |
neuronal PAS domain protein 2 |
|
decreases expression |
ISO |
9 |
38,255,362 |
38,434,352 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
increases expression |
ISO |
4 |
56,949,553 |
57,048,149 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
decreases expression |
ISO |
2 |
179,838,740 |
179,855,545 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
decreases expression |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
|
decreases expression |
EXP |
1 |
236,592,414 |
236,677,379 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
increases expression |
EXP |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
decreases expression |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pbx1 |
pre-B-cell leukemia homeobox 1 |
|
decreases expression |
ISO |
13 |
83,839,256 |
84,115,516 |
RGD:6480464 |
CTD |
| G |
Pcbp4 |
poly(rC) binding protein 4 |
|
increases expression |
ISO |
8 |
111,597,539 |
111,607,775 |
RGD:6480464 |
CTD |
| G |
Pcgf2 |
polycomb group ring finger 2 |
|
decreases expression |
ISO |
10 |
86,439,109 |
86,443,193 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
decreases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pfn1 |
profilin 1 |
|
increases expression |
EXP |
10 |
57,531,661 |
57,534,366 |
RGD:6480464 |
CTD |
| G |
Phf20 |
PHD finger protein 20 |
|
increases expression |
ISO |
3 |
146,601,763 |
146,707,185 |
RGD:6480464 |
CTD |
| G |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
|
increases expression |
ISO |
1 |
7,882,674 |
7,922,504 |
RGD:6480464 |
CTD |
| G |
Pml |
promyelocytic leukemia |
|
decreases expression |
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
affects localization |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
affects localization |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
decreases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prmt5 |
protein arginine methyltransferase 5 |
|
increases expression |
ISO |
15 |
32,574,951 |
32,584,336 |
RGD:6480464 |
CTD |
| G |
Prpf6 |
PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae) |
|
increases expression |
EXP |
3 |
170,740,406 |
170,804,674 |
RGD:6480464 |
CTD |
| G |
Psmb5 |
proteasome (prosome, macropain) subunit, beta type 5 |
|
increases expression |
EXP |
15 |
32,689,859 |
32,694,364 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
increases expression |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
increases expression |
EXP |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
EXP |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
increases expression |
EXP |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
increases expression |
EXP |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Rbak |
RB-associated KRAB zinc finger |
|
decreases expression |
ISO |
12 |
11,748,333 |
11,760,544 |
RGD:6480464 |
CTD |
| G |
Rbbp6 |
retinoblastoma binding protein 6 |
|
decreases expression |
ISO |
1 |
181,818,248 |
181,849,942 |
RGD:6480464 |
CTD |
| G |
Rest |
RE1-silencing transcription factor |
|
decreases expression |
ISO |
14 |
33,136,046 |
33,151,142 |
RGD:6480464 |
CTD |
| G |
Rfxank |
regulatory factor X-associated ankyrin-containing protein |
|
decreases expression |
ISO |
16 |
19,764,913 |
19,772,281 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
decreases expression |
EXP |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Runx1t1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
|
decreases expression |
ISO |
5 |
28,230,322 |
28,338,441 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
increases expression |
EXP |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
increases expression |
EXP |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
increases expression |
EXP |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
increases expression |
EXP |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
Serpina7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
decreases expression |
EXP |
X |
126,739,203 |
126,744,763 |
RGD:6480464 |
CTD |
| G |
Sh3bp4 |
SH3-domain binding protein 4 |
|
decreases expression |
ISO |
9 |
88,227,341 |
88,243,397 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
increases expression |
EXP |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
decreases expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
EXP |
1 |
211,375,889 |
211,390,313 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
decreases expression |
EXP |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
multiple interactions |
ISO |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
increases response to substance |
ISO |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Smad4 |
SMAD family member 4 |
|
decreases expression |
ISO |
18 |
70,432,705 |
70,461,541 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
decreases expression |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases activity |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sox18 |
SRY (sex determining region Y)-box 18 |
|
increases expression |
ISO |
3 |
170,820,460 |
170,822,262 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
increases activity |
EXP |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp2 |
Sp2 transcription factor |
|
increases expression |
ISO |
10 |
85,676,978 |
85,706,042 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
decreases expression |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srd5a2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
increases expression |
EXP |
6 |
21,453,521 |
21,489,408 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stim1 |
stromal interaction molecule 1 |
|
decreases expression |
ISO |
1 |
159,761,567 |
159,925,836 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
decreases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1b1 |
sulfotransferase family, cytosolic, 1B, member 1 |
|
increases expression |
EXP |
14 |
22,019,193 |
22,031,914 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
increases expression |
EXP |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
increases expression |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Taf2 |
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
decreases expression |
ISO |
7 |
91,542,400 |
91,599,759 |
RGD:6480464 |
CTD |
| G |
Tbrg4 |
transforming growth factor beta regulator 4 |
|
increases expression |
ISO |
14 |
87,372,275 |
87,378,266 |
RGD:6480464 |
CTD |
| G |
Tead3 |
TEA domain family member 3 |
|
increases expression |
ISO |
20 |
6,572,336 |
6,591,723 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
increases expression |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
increases expression |
EXP |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Tia1 |
TIA1 cytotoxic granule-associated RNA binding protein |
|
decreases expression |
ISO |
4 |
120,590,164 |
120,617,530 |
RGD:6480464 |
CTD |
| G |
Tm2d1 |
TM2 domain containing 1 |
|
decreases expression |
ISO |
5 |
118,765,552 |
118,806,996 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf12 |
tumor necrosis factor ligand superfamily member 12 |
|
decreases expression |
ISO |
10 |
56,503,756 |
56,513,053 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
EXP |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trim16 |
tripartite motif-containing 16 |
|
increases expression |
ISO |
10 |
48,987,004 |
49,009,696 |
RGD:6480464 |
CTD |
| G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
|
decreases expression |
ISO |
4 |
69,331,973 |
69,347,633 |
RGD:6480464 |
CTD |
| G |
Tsc22d3 |
TSC22 domain family, member 3 |
|
increases expression |
ISO |
X |
128,336,408 |
128,340,027 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
multiple interactions |
EXP |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
decreases expression |
EXP |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
increases expression |
EXP |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
multiple interactions |
ISO |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
decreases activity |
ISO |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
increases expression |
EXP |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Ube2v1 |
ubiquitin-conjugating enzyme E2 variant 1 |
|
increases expression |
ISO |
3 |
158,745,873 |
158,768,725 |
RGD:6480464 |
CTD |
| G |
Ubn1 |
ubinuclein 1 |
|
increases expression |
ISO |
10 |
10,612,480 |
10,647,870 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
increases expression |
ISO |
9 |
87,081,132 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a5 |
UDP glucuronosyltransferase 1 family, polypeptide A5 |
|
increases expression |
ISO |
9 |
87,052,169 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
ISO |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt2b15 |
UDP glucuronosyltransferase 2 family, polypeptide B15 |
|
affects expression |
ISO |
14 |
22,346,334 |
22,366,860 |
RGD:6480464 |
CTD |
| G |
Ugt2b15 |
UDP glucuronosyltransferase 2 family, polypeptide B15 |
|
increases expression |
ISO |
14 |
22,346,334 |
22,366,860 |
RGD:6480464 |
CTD |
| G |
Ugt2b17 |
UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
increases expression |
EXP |
14 |
22,639,182 |
22,650,931 |
RGD:6480464 |
CTD |
| G |
Ugt2b17 |
UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
increases expression |
ISO |
14 |
22,639,182 |
22,650,931 |
RGD:6480464 |
CTD |
| G |
Ugt2b17 |
UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
affects expression |
ISO |
14 |
22,639,182 |
22,650,931 |
RGD:6480464 |
CTD |
| G |
Ugt2b35 |
UDP glucuronosyltransferase 2 family, polypeptide B35 |
|
increases expression |
ISO |
14 |
22,454,256 |
22,493,510 |
RGD:6480464 |
CTD |
| G |
Ugt2b7 |
UDP glucuronosyltransferase 2 family, polypeptide B7 |
|
increases expression |
ISO |
14 |
22,499,152 |
22,522,842 |
RGD:6480464 |
CTD |
| G |
Vcp |
valosin-containing protein |
|
increases expression |
EXP |
5 |
59,472,100 |
59,491,508 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
increases expression |
EXP |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
|
increases expression |
ISO |
3 |
25,513,009 |
25,654,964 |
RGD:6480464 |
CTD |
| G |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
|
increases expression |
ISO |
6 |
103,119,555 |
103,124,576 |
RGD:6480464 |
CTD |
Term paths to the root
|